It Matters How You Ask- Parsing Out Pros And Other COA Items

Published May 17, 2013
State College, PA, USA – Increasingly, information about the benefits of a treatment is being obtained directly from patients, clinicians, and patients’ observers using clinical outcomes assessments (COAs). Clinical outcomes assessments are used to inform individual medical decisions as well as the drug approval process.  As a result of the growing importance of COAs, their number and diversity have increased exponentially to meet the needs of assessing concepts of health and well-being across a range of therapeutic areas. At the most basic level, COAs include core concepts that are considered to be fundamental elements of broader concepts. Dr. Pennifer Erickson (OLGA) and Dr. Richard Willke (Pfizer) evaluated the syntax and language of these core concepts for their study, “Examining Item Content and Structure in Health Status and Health Outcomes Instruments: Toward the Development of a Grammar for Better Understanding of the Concepts Being Measured,” published in Value in Health.  In the paper, the authors describe how they developed a descriptive grammar that can guide users on how to identify core concepts, understand each concept’s role in evaluating and making a statement of treatment benefit, and demonstrate the variety of ways that a core concept can be evaluated. This systematic approach to evaluating and classifying conceptual concepts in COAs aims to link patients’ reports of treatment benefit directly to health decision making at the clinical practice and macro policy level. Dr. Erickson explains, "The same core health concept can be queried in various ways depending on key wording within an item; we call the rules governing the phrasing within each items its grammar.  A high level of validity and comparability of interpretation across items relies on both the use and understanding of their grammatical structure."

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

ISPOR Tackles Health Disparities with New Research Primer

Jan 22, 2025

ISPOR announced today the publication of a report from the ISPOR Health Equity Research Special Interest Group intended to establish key concepts for conducting health equity research that enables investigators to examine—and ultimately reduce—unfair social inequities in health.

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×